Skip to main content

Closed

MRKR: Marker Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

19thpctl

Volume

0.61×avg

Market Cap

12.20MUSD

P/E Ratio

-1.7TTM

Div Yield

-ann

Marker Therapeutics, Inc.

MRKRNASDAQ Capital Market·USD·Closed

Marker Therapeutics, Inc.

MRKRNASDAQ·USD·Closed

$1.13

+0.89%

$1.13

+$0.01 (0.89%)

52W Range

19thpctl

Volume

0.61×avg

Mkt Cap

12.20MUSD

P/E

-1.7TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings